Carson Wealth (CWM LLC)’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$113 Sell
29
-26
-47% -$64 ﹤0.01% 5570
2025
Q4
$0 Sell
55
-127
-70% -$208 ﹤0.01% 5541
2025
Q3
$0 Sell
182
-2,818
-94% -$2.07K ﹤0.01% 5441
2025
Q2
$2K Buy
3,000
+1,418
+90% +$1.06K ﹤0.01% 4901
2025
Q1
$1K Sell
1,582
-4,621
-74% -$6.87K ﹤0.01% 4949
2024
Q4
$10K Buy
6,203
+5,841
+1,614% +$14K ﹤0.01% 3882
2024
Q3
$1K Buy
362
+119
+49% +$308 ﹤0.01% 4640
2024
Q2
$1K Buy
243
+240
+8,000% +$627 ﹤0.01% 4427
2024
Q1
$0 Buy
+3
New +$9 ﹤0.01% 4589
2022
Q4
Sell
-320
Closed -$1K 4147
2022
Q3
$1K Buy
+320
New +$805 ﹤0.01% 3706

Other funds holding NAUT

Carson Wealth (CWM LLC)'s NAUT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Nautilus Biotechnolgy (NAUT) stake by 47% in Q1 2026, selling an estimated $64 and leaving 29 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #5570.

Carson Wealth (CWM LLC) first reported a position in NAUT in Q3 2022 and has held it in 10 quarters since. The position peaked at $10K in Q4 2024. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 29 shares of Nautilus Biotechnolgy worth $113 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 26 Nautilus Biotechnolgy shares in Q1 2026, an estimated $64.
  • Nautilus Biotechnolgy made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5570 holding.
  • Carson Wealth (CWM LLC) first reported a position in Nautilus Biotechnolgy in Q3 2022 and has held it in 10 quarters since.
  • Carson Wealth (CWM LLC)'s Nautilus Biotechnolgy position peaked at $10K in Q4 2024.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.